Benzinga | Nov 9, 2021 05:21PM EST

TransMedics Group Q3 EPS $(0.47) Misses $(0.36) Estimate, Sales $5.40M Miss $6.35M Estimate; Sees FY21 Sales $27.6M-$28.6M vs $33M Estimate

TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) by 30.56 percent. This is a 147.37 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $5.40 million which missed the analyst consensus estimate of $6.35 million by 14.96 percent. This is a 23.85 percent decrease over sales of $7.09 million the same period last year.